30/05/2024  21:59:56 Chg. +0.92 Volume Bid- Demandez à- Capitalisation boursière Dividende Y. Rapport P/E
26.10USD +3.63% 22,115
Chiffrre d'affaires: 569,072.41
-Bid taille: - -Ask la taille: - 285.46 Mio.USD 18.97% 2.86

Description de l'entreprise

Medifast (NYSE: MED) is the leading easy-to-use, clinically proven provider of weight-loss and healthy living products and programs. Medifast aims to help customers lead a healthier lifestyle through a holistic approach to weight-loss and weight management, nutrition education and fitness. Medifast's proven results are based on the use of structured meal plans featuring Medifast Meals, which are nutritionally designed to assist customers with successful weight-loss and weight management. The company sells its products and programs via four unique distribution channels: 1) the web and national call centers, 2) the Take Shape For Life personal coaching division, 3) Medifast Weight Control Centers, and 4) a national network of physicians. The company also offers sports nutrition products under the brand Dual Fuel™ Nutrition that are formulated to provide athletes and active individuals with the right balance of carbohydrates and high quality protein for top performance. Medifast was founded in 1980 and is located in Owings Mills, Maryland.
 

Conseil d'administration & Conseil de surveillance

PDG
Daniel Chard
Conseil d'administration
James Maloney, Claudia Greninger, Jason L. Groves, Esq., Lauren Walker, Nicholas Johnson, Tony Tyree
Conseil de surveillance
Andrea B. Thomas, Constance J. Hallquist, Daniel R. Chard, Jeffrey J. Brown, Kevin G. Byrnes, Michael A. Hoer, Scott Schlackman, Xian Ming
 

Données de l'entreprise

Nom: Medifast Inc.
Adresse: 100 International Drive,Baltimore, Maryland 21202, USA
Téléphone: +1-410-581-8042
Fax: -
Courriel: -
Internet: www.medifast1.com/
Industrie: Healthcare
Secteur: Pharmaceutical Industry
Sous-secteur: Pharmaceuticals
Fin de l'exercice financier: 31/12
Flotte libre: 65.90%
IPO date: -

Relations avec les investisseurs

Nom: Katie Turner
Téléphone IR: +1-646-277-1228
IR-Fax: -
E-mail IR: -

Principaux actionnaires

Freefloat
 
65.90%
BlackRock, Inc.
 
14.70%
The Vanguard Group
 
10.70%
Renaissance Funds
 
8.70%